As part of the Third Dynamic Competition Initiative (DCI) Conference, a panel discussion with Bowman Heiden, Lorenzo Allio, Miguel Poiares Maduro, and Branislav Turcina examined the relationship between European regulation and innovation, the Draghi report, and the Constitution of Innovation (CoI).
Read MoreEira Conference October 2026: Competing for the Cure: Intellectual Property, Innovation Policy, and Biopharmaceutical Ecosystems
We are pleased to announce the upcoming conference hosted by the Eira Initiative in association with the Berkeley Policy Institute: Competing for the Cure: Intellectual Property, Innovation Policy, and Biopharmaceutical Ecosystems (October 29–30, 2026).
Read MoreAmicus Brief to D.C. Circuit Court in United States v. Google
A notable group of thought leaders addressing innovation law and economics, including Berkeley Policy Institute (BPI) executive director David J. Teece, have submitted an amicus brief to the U.S. Court of Appeals for the D.C. Circuit regarding United States v. Google LLC.
Read MoreDynamic Universities: Strategic Leadership for Higher Education’s Turbulent Future
in Management, Leadership
In a May 2026 post in CMR Insights, Professor David Teece and Professor Sohvi Heaton offer key guidance for university executives and boards to manage their institutions through challenging times in the sector.
Read MoreWhat do the numbers reveal on whether merger policy is ‘too permissive’ or ‘too strict’?
Company mergers, and the regulations surrounding them, occupy a central policy debate among lawmakers, scholars, and the general public in many countries. A core question emerges from this pressing topic: How to best interpret the data about merger prohibition rates and merger deterrence?
Read MoreEvergreening's Empirical Chasm: A Working Paper from the Eira Initiative
A working paper from the Eira Initiative examines data on pharmaceutical innovation. The author, Professor Erika Lietzan, finds that the evergreening narrative (which alleges companies patent revisions to drugs to prolong intellectual property protection) is conceptually flawed, misrepresents how patents and exclusivity intersect with drug approval frameworks, and risks misleading policymakers into enacting measures that would punish innovation to the detriment of patients.
Read MoreAntitrust Analysis from Professor Jonathan Barnett on Recent Cases
Writing in Truth on the Market, Professor Jonathan Barnett investigates several recent merger cases, and how regulator decisions might have harmed economic value, consumers, and employees.
Read MoreProfessor Chris Pitelis Interview on Orchestration, Value Creation, and the Public Good
in Management, Strategy
Professor Chris Pitelis has a new interview video available on his research and scholarship, in which he relates multiple topics across economics and management areas, including dynamic capabilities and a 2018 paper co-authored with David Teece.
Read MoreProfessor Mary-Anne Williams Post on Agentic AI and Dynamic Capabilities
in Strategy, Management
Professor Mary-Anne Williams has written a detailed post with an accompanying presentation slide deck on LinkedIn, addressing the interrelated topics of agentic AI, human-AI collaboration, and novel approaches for adaptable orchestration strategies.
Read More3rd DCI Conference Videos Available on YouTube
in DCI
Multiple videos from the Third Annual Dynamic Competition Initiative (DCI) Conference, held in April 2026, are now available to watch on YouTube.
Read MorePenrose Lectures at SOAS University of London: April 28 & 29, 2026
in Strategy
Is Edith Penrose today more relevant than ever?
Professor Chris Pitelis will deliver this year’s Penrose Public Lectures at SOAS University of London.
📅 Tuesday 28 & Wednesday 29 April, 2026
How the American Research University Survives
Writing in Issues in Science and Technology, Robert Brown and Bruce Guile explore the current state of American higher education and research enterprise sectors.
Read MoreAI + Intellectual Capital + IP: New Challenges and Opportunities for Companies
in Strategy
Writing as a guest for The Intangible Investor column in IPWatchdog, David Teece examines the growing use of artificial intelligence, and its implications for the intellectual capital and intellectual property rights of firms.
Read MoreOp-Ed on Regulatory Exclusivity for Pharmaceutical Innovation
Many political leaders increasingly view regulatory exclusivity as a lucrative handout to pharmaceutical companies. In a new DC Journal op-ed, Professor Kristina M. L. Acri née Lybecker explains why that narrative is mistaken -- and cautions against policies that would weaken exclusivity and discourage the investments that lead to new medicines.
Read MoreNew Policy Brief: The Economics of Skinny Labels
With the Supreme Court set to hear Hikma Pharmaceuticals USA Inc. v. Amarin Pharma, Inc., key questions are coming into focus. How might the Court's decision reshape strategies for brand-name and generic manufacturers? And what risks will companies face when marketing “skinny label” products?
Read MoreLaunch of the Journal of Dynamic Competition
The Journal of Dynamic Competition (JDC) debuted on March 27, 2026 at the ABA Antitrust Spring Meeting in Washington, DC.
Read MoreConstitution of Innovation Launch Event: Video Available on YouTube
in DCI
In a milestone event for competition policy, law, and economics, scholars convened at European University Institute on February 17, 2026 to launch the Constitution of Innovation.
Read MoreSurvival Guide for the STEM Research and Education Enterprise at US Universities
A working group of experts assembled in early 2026 to author a practical guide for universities in the United States, yielding a practical working paper for boards and leadership.
Read More